Content
06/17/2025
Waltham, MA USA
Glytec
completed $36 million Growth Round funding. Investors include
Hayfin Capital Management (lead), Savitr Capital (lead).
About
Glytec's industry-leading technology platform, trusted by over 400 hospitals, empowers collaborative diabetes management and insulin dosing, improving patient outcomes, reducing hospital length of stay, and optimizing clinical workflows. It's flagship product, Glucommander® -- the first-ever FDA-cleared cloud-based insulin management software -- integrates seamlessly with EMRs, providing advanced clinical decision support, workflow alerts, patient monitoring, and AI-driven analytics. Supported by over 100 patents and 100 clinical and peer-reviewed publications, Glytec is dedicated to improving metabolic care from hospital to home.
Startup
Sector:
Digital Health
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
